3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
8
Ovarian Neoplasms
7
Rectal Neoplasms
4
Colonic Neoplasms
4
Peritoneal Neoplasms
2
Pancreatic Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Robotic
1
Prostatic Neoplasms
1
Pancreatic Neuroendocrine Tumors
1
Ovarian Cysts
1
Neoplasms
1
Myofibroma
1
Kidney Neoplasms
1
Genital Neoplasms, Female
1
Gastrointestinal Stromal Tumors
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Endometrial Adenocarcinoma
1
Drug-Related Side Effects and Adverse Reactions
1
Diverticulitis
1
Crohn Disease
1
Colonic Polyps
1
Interventions
Saline Solution
3
Uterine Artery Embolization
2
Tourniquets
2
Misoprostol
2
Lidocaine
2
ulipristal
1
telapristone acetate
1
remimazolam
1
relugolix
1
pirfenidone
1
estradiol, norethindrone drug combination
1
dienogest
1
carbetocin
1
Vasopressins
1
Uterine Myomectomy
1
Triptorelin Pamoate
1
Sodium Chloride
1
Sevoflurane
1
Respiration, Artificial
1
Remifentanil
1
Propofol
1
Population Groups
1
Morcellation
1
Leuprolide
1
Laparoscopy
1
LFA102 monoclonal antibody
1
Indocyanine Green
1
Hysterectomy
1
Dinoprostone
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Myofibroma
×
Laparoscopy
×
Clear all
NCT06067971
2025-09-12
ENDORA2
University Hospital, Clermont-Ferrand
Phase NA
Completed
40 enrolled